Identifying Genes That May Increase the Risk for Heart Disease in African Americans
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00344136|
Recruitment Status : Completed
First Posted : June 26, 2006
Last Update Posted : July 29, 2016
|Condition or disease|
African Americans have a high risk of developing heart disease and stroke, and are more likely to die from heart-related illnesses than other racial and ethnic groups. A large majority of African Americans are descendants of both African and European ancestors who mixed five to six generations ago. Because only a few generations have passed since that time, it is still possible to identify specific genes, the basic units of heredity, as being either African or European in origin. This is a sub study of the Jackson Heart Study, which is examining the environmental and genetic factors that influence the development of heart disease in African Americans. In this study, researchers will examine genes from participants in the Jackson Heart Study to identify specific African and European genes that influence the development of heart disease in African American men and women.
This study will use genetic samples from individuals participating in the Jackson Heart Study. There will be no study visits for participants. Study researchers will examine the genetic samples and identify specific African and European genes that may influence the development of heart disease, high blood pressure, lipid disorders, left ventricular hypertrophy, and low birth weight.
|Study Type :||Observational|
|Enrollment :||5302 participants|
|Official Title:||Health Disparities and CVD: Admixture Mapping in the Jackson Heart Study|
|Study Start Date :||September 2000|
|Actual Study Completion Date :||March 2004|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00344136
|United States, Mississippi|
|University of Mississippi School of Medicine|
|Jackson, Mississippi, United States, 39216|
|Principal Investigator:||James G. Wilson, MD||University of Mississippi Medical Center and VA Medical Center, Jackson, MS|